Parkinson Disease < Parkinson Disease (blood) < Parkinson Disease (cerebrospinal fluid)

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 23.
[0-20] [0 - 20][0 - 23][20-22][20-40]

Ident.	Authors (with country if any)	Title
000188 (2001)	R. Schimpff ; C. Avard ; G. Fenelon ; A. Lhiaubet ; L. Tenneze ; M. Vidailhet ; W. Rostene	Increased plasma neurotensin concentrations in patients with Parkinson's disease
000319 (????)	R. Bordet [France] ; D. Devos ; S. Brique ; Y. Touitou ; J D Guieu ; C. Libersa ; A. Destée	Study of circadian melatonin secretion pattern at different stages of Parkinson's disease.
000428 (2004)	Nicolas Simon [France] ; Radka Gantcheva ; Bernard Bruguerolle ; François Viallet	The effects of a normal protein diet on levodopa plasma kinetics in advanced Parkinson's disease.
000480 (2004)	M. Bouhaddi [France] ; F. Vuillier ; J O Fortrat ; S. Cappelle ; M T Henriet ; L. Rumbach ; J. Regnard	Impaired cardiovascular autonomic control in newly and long-term-treated patients with Parkinson's disease: involvement of L-dopa therapy.
000490 (2004)	Joana Vitte [France] ; Bernard F. Michel ; Pierre Bongrand ; Jean-Louis Gastaut	Oxidative stress level in circulating neutrophils is linked to neurodegenerative diseases.
000505 (2005)	Nicolas Simon [France] ; Joëlle Micallef ; Jean-Charles Reynier ; Monique Lesourd ; Tatiana Witjas ; André Alicherif ; Jean-Philippe Azulay ; Olivier Blin	End-of-dose akinesia after a single intravenous infusion of the dopaminergic agonist piribedil in Parkinson's disease patients: a pharmacokinetic/pharmacodynamic, randomized, double-blind study.
000524 (2006)	Agnes Janoshazi [France] ; François Sellal ; Christian Marescaux ; Jean-Marie Danion ; Jean Marie Warter ; Jean De Barry	Alteration of protein kinase C conformation in red blood cells: a potential marker for Alzheimer's disease but not for Parkinson's disease.
000566 (2006)	Jean-Pierre Wolf [France] ; Malika Bouhaddi ; Francis Louisy ; Andrei Mikehiev ; Laurent Mourot ; Sylvie Cappelle ; Fabrice Vuillier ; Pierre Andre ; Lucien Rumbach ; Jacques Regnard	Side-effects of L-dopa on venous tone in Parkinson's disease: a leg-weighing assessment.
000568 (2005)	L. Salauze [France] ; C. Van Der Velden ; I. Lagroye ; B. Veyret ; M. Geffard	Circulating antibodies to cysteinyl catecholamines in amyotrophic lateral sclerosis and Parkinson's disease patients.
000579 (2005)	Nathalie Vaserman [France]	Parkinson's disease and osteoporosis.
000B36 (1991)	G. Durrieu [France] ; J M Senard ; M A Tran ; A. Rascol ; J L Montastruc	Effects of levodopa and bromocriptine on blood pressure and plasma catecholamines in parkinsonians.
000D54 (1990)	G. Durrieu [France] ; Y. Rispail ; E. Chatelut ; M. Berlan ; A. Rascol ; J L Montastruc ; P. Montastruc	Beta-adrenergic sensitivity in Parkinson's disease: effect of levodopa treatment.
000E39 (2012)	Hélène Pouclet [France] ; Thibaud Lebouvier ; Mathurin Flamant ; Emmanuel Coron ; Michel Neunlist ; Pascal Derkinderen ; Tiphaine Rouaud	[Autonomic nervous system as a source of biomarkers in Parkinson's disease].
001023 (1990)	G. Durrieu [France] ; J M Senard ; O. Rascol ; M A Tran ; X. Lataste ; A. Rascol ; J L Montastruc	Blood pressure and plasma catecholamines in never-treated parkinsonian patients: effect of a selective D1 agonist (CY 208-243).
001577 (1989)	M. Berlan [France] ; O. Rascol ; J. Belin ; J P Moatti ; A. Rascol ; J L Montastruc	Alpha 2-adrenergic sensitivity in Parkinson's disease.
001D28 (1994)	F. Tison [France] ; N. Fouillet ; P. Henry	Apomorphine increases blood glucose concentrations in Parkinson's disease.
001D53 (1993)	W. Camu [France] ; M. Billiard ; M. Baldy-Moulinier	Fasting plasma and CSF amino acid levels in amyotrophic lateral sclerosis: a subtype analysis.
001D64 (1993)	J M Senard [France] ; O. Rascol ; G. Durrieu ; M A Tran ; M. Berlan ; A. Rascol ; J L Montastruc	Effects of yohimbine on plasma catecholamine levels in orthostatic hypotension related to Parkinson disease or multiple system atrophy.
001D84 (1995)	P. Allain [France] ; A. Le Bouil ; E. Cordillet ; L. Le Quay ; H. Bagheri ; J L Montastruc	Sulfate and cysteine levels in the plasma of patients with Parkinson's disease.
001E00 (1995)	P. Limousin [France] ; P. Pollak ; J P Pfefen ; C L Tournier-Gervason ; R. Dubuis ; J E Perret	Acute administration of levodopa-benserazide and tolcapone, a COMT inhibitor, Parkinson's disease.
001E33 (1996)	M E Llau [France] ; G. Durrieu ; M A Tran ; J M Senard ; O. Rascol ; J L Montastruc	A study of dopaminergic sensitivity in Parkinson's disease: comparison in "de novo" and levodopa-treated patients.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Parkinson Disease (blood)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Parkinson Disease (blood)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Parkinson Disease (blood)
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024